Advanced Biomedical Technologies Inc (ABMT) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ABMT Annual Balance Sheets →
The balance sheet figures below highlight longer-term patterns in how Advanced Biomedical Technologies Inc finances operations and invests in assets.
Quarterly Report, GAAP in USD millions
ITEM
(Jul 31 2021)
(Apr 30 2021) (Jan 31 2021) (Oct 31 2020) (Jul 31 2020)
Assets
Cash & cash equivalent0.01
Cash & Short-term Investments0.00
Inventories0.19
Prepaid Expense And Other Assets Current0.05
Total Current Assets0.24
Equipment/Property/Plant Net0.14
Other Assets, Noncurrent0.01
Total Assets0.40
Liabilities
Accounts Payable and Accrued Liabilities, Current LI1.16
Other Accounts Payable AndAccrued Liabilities0.71
Other Liabilities, Current5.43
Total Current Liabilities8.58
Total Long-term Debt0.00
Other liabilities, Noncurrent0.00
Due To Directors0.01
Operating Lease Liability Noncurrent-
Total Liabilities8.58
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock2.84
Retained Earnings / Accumulated Deficit-10.82
Other Equity-0.20
Common Stockholder's Equity-8.18
Total Stockholder's Equity-8.18
Liabilities & Stockholder's Equity0.40
4 historic quarters locked

Sign in to unlock the full Advanced Biomedical Technologies Inc balance sheet history.

About ABMT Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.